Stock 197A TAUNS LABORATORIES,INC.
Add to a list
To use this feature you must be a member
Log inSign up

TAUNS Laboratories,Inc. Stock

Equities

197A

JP3452250008

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-08 EDT 		5-day change 1st Jan Change
413 JPY +0.73% Intraday chart for TAUNS Laboratories,Inc. +0.73% 0.00%
06-20 TAUNS Laboratories,Inc. has completed an IPO in the amount of ¥9.7014 billion. CI

Financials

Sales 2024 * 17.68B 110M 150M Sales 2025 * 18.99B 118M 161M Capitalization 41.3B 257M 350M
Net income 2024 * 5.52B 34.36M 46.84M Net income 2025 * 5.99B 37.27M 50.81M EV / Sales 2024 * 2.33 x
Net cash position 2024 * 154M 955K 1.3M Net Debt 2025 * 3.76B 23.36M 31.84M EV / Sales 2025 * 2.37 x
P/E ratio 2024 *
7.48 x
P/E ratio 2025 *
6.89 x
Employees 218
Yield 2024 *
4.09%
Yield 2025 *
6.42%
Free-Float 25.73%
More Fundamentals * Assessed data

Chart TAUNS Laboratories,Inc.

Dynamic Chart

Latest news about TAUNS Laboratories,Inc.

TAUNS Laboratories,Inc. has completed an IPO in the amount of ¥9.7014 billion. CI
More news

Quotes and Performance

1 day+0.73%
1 week+0.73%
Current month+0.73%
More quotes

Highs and lows

1 week
406.00
Extreme 406
418.00
1 month
405.00
Extreme 405
459.00
Current year
405.00
Extreme 405
459.00
1 year
405.00
Extreme 405
459.00
3 years
405.00
Extreme 405
459.00
5 years
405.00
Extreme 405
459.00
10 years
405.00
Extreme 405
459.00
More quotes

Quotes

Date Price Change Volume
24-07-08 413 +0.73% 553 000
24-07-05 410 0.00% 362,700
24-07-04 410 0.00% 663,500
24-07-03 410 0.00% 452,800
24-07-02 410 -1.68% 463,100

Delayed Quote Japan Exchange, July 08, 2024 at 02:00 am

More quotes

Company Profile

Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
Sector
Medical Equipment, Supplies & Distribution
More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
413 JPY
Average target price
460 JPY
Spread / Average Target
+11.38%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
TAUNS LABORATORIES,INC. Stock TAUNS Laboratories,Inc.
0.00% 255M
BIOMÉRIEUX Stock bioMérieux
-8.55% 12.02B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-22.07% 6.81B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+27.13% 5.47B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-24.14% 3.59B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+4.11% 2.56B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+31.97% 2.25B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-67.03% 2.24B
VITROLIFE AB Stock Vitrolife AB
-12.07% 2.21B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-17.96% 1.52B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 197A Stock